β-Arrestin-biased ligands at seven-transmembrane receptors

受体 跨膜蛋白 神经科学 逮捕 心理学 跨膜结构域 沟通 化学 G蛋白偶联受体 生物化学
作者
Jonathan D. Violin,Robert J. Lefkowitz
出处
期刊:Trends in Pharmacological Sciences [Elsevier BV]
卷期号:28 (8): 416-422 被引量:572
标识
DOI:10.1016/j.tips.2007.06.006
摘要

Seven-transmembrane receptors (7TMRs), the most common molecular targets of modern drug therapy, are critically regulated by β-arrestins, which both inhibit classic G-protein signaling and initiate distinct β-arrestin signaling. The interplay of G-protein and β-arrestin signals largely determines the cellular consequences of 7TMR-targeted drugs. Until recently, a drug's efficacy for β-arrestin recruitment was believed to be proportional to its efficacy for G-protein activities. This paradigm restricts 7TMR drug effects to a linear spectrum of responses, ranging from inhibition of all responses to stimulation of all responses. However, it is now clear that ‘biased ligands’ can selectively activate G-protein or β-arrestin functions and thus elicit novel biological effects from even well-studied 7TMRs. Here, we discuss the current state of β-arrestin-biased ligand research and the prospects for β-arrestin bias as a therapeutic target. Consideration of ligand bias might have profound influences on the way scientists approach 7TMR-targeted drug discovery. Seven-transmembrane receptors (7TMRs), the most common molecular targets of modern drug therapy, are critically regulated by β-arrestins, which both inhibit classic G-protein signaling and initiate distinct β-arrestin signaling. The interplay of G-protein and β-arrestin signals largely determines the cellular consequences of 7TMR-targeted drugs. Until recently, a drug's efficacy for β-arrestin recruitment was believed to be proportional to its efficacy for G-protein activities. This paradigm restricts 7TMR drug effects to a linear spectrum of responses, ranging from inhibition of all responses to stimulation of all responses. However, it is now clear that ‘biased ligands’ can selectively activate G-protein or β-arrestin functions and thus elicit novel biological effects from even well-studied 7TMRs. Here, we discuss the current state of β-arrestin-biased ligand research and the prospects for β-arrestin bias as a therapeutic target. Consideration of ligand bias might have profound influences on the way scientists approach 7TMR-targeted drug discovery. a ligand that, by binding a receptor, increases that receptor's activity. a ligand that binds a receptor without stimulating any activity. Also known as a ’blocker’ because of its ability to prevent binding of other ligands and, therefore, block agonist-induced activity. when ligand binding stimulates or inhibits all receptor functions to an equal extent; thus, the relative efficacy of a ligand for any signal is identical to the relative efficacy of that ligand for any other signal. ligand stimulation of multiple receptor activities with different relative efficacies for different signals; thus, the selectivity of the ligand is not absolute. an antagonist that, in addition to blocking agonist effects, reduces receptors’ basal, constitutive activity. the ability of a ligand to selectively stimulate a subset of a receptor's activities. Such ligands are known as ‘biased ligands’, ‘biased agonists’ or ‘functionally selective agonists’. a special case of an antagonist that neither stimulates any signals nor inhibits intrinsic receptor activity. an agonist that results in a sub-maximal response, even when receptors are fully occupied. Partial agonists can also function as ‘blockers’ by preventing the binding of more-robust agonists. ligand stimulation of one receptor activity without any stimulation of another known receptor activity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
恐惧发布了新的文献求助30
刚刚
1秒前
1秒前
2秒前
coozrasimon完成签到,获得积分20
2秒前
wanci的应助被int0采纳,获得10
2秒前
2秒前
飞鸿影下发布了新的文献求助10
2秒前
3秒前
3秒前
务实寄凡完成签到,获得积分10
3秒前
隐形曼青的应助被好好好采纳,获得10
3秒前
铎铎铎完成签到 ,获得积分0
3秒前
3秒前
decimalpoint完成签到,获得积分10
3秒前
enen发布了新的文献求助10
4秒前
didi发布了新的文献求助30
6秒前
feifei发布了新的文献求助10
6秒前
yy发布了新的文献求助10
7秒前
orixero的应助被Kiki采纳,获得10
7秒前
凉白开完成签到,获得积分10
7秒前
7秒前
汉堡包的应助被小瑶采纳,获得10
7秒前
7秒前
思源的应助被秦志文采纳,获得10
8秒前
8秒前
蓝天发布了新的文献求助200
8秒前
wuliweiwei完成签到,获得积分10
9秒前
10秒前
陈雅茹发布了新的文献求助10
10秒前
希望天下0贩的0的应助被墨白采纳,获得10
10秒前
Hello的应助被科研通管家采纳,获得10
10秒前
完美世界的应助被科研通管家采纳,获得10
10秒前
NexusExplorer的应助被科研通管家采纳,获得10
10秒前
C.Cat的应助被科研通管家采纳,获得10
11秒前
桐桐的应助被科研通管家采纳,获得10
11秒前
爆米花的应助被科研通管家采纳,获得10
11秒前
11秒前
CipherSage的应助被科研通管家采纳,获得10
11秒前
小杨梅发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156